Mechanism of vasodilation to adenosine in coronary arterioles from patients with heart disease.

Adenosine is a key myocardial metabolite that elicits coronary vasodilation in a variety of pathophysiological conditions. We examined the mechanism of adenosine-induced vasodilation in coronary arterioles from patients with heart disease. Human coronary arterioles (HCAs) were dissected from pieces of the atrial appendage obtained at the time of cardiac surgery and cannulated for the measurement of internal diameter with videomicroscopy. Adenosine-induced vasodilation was not inhibited by endothelial denudation, but A(2) receptor antagonism with 3,7-dimethyl-1-propargylxanthine and adenylate cyclase (AC) inhibition with SQ22536 significantly attenuated the dilation. In contrast, A(1) receptor antagonism with 8-cyclopentyl-1,3-dipropylxanthine significantly augmented the sensitivity to adenosine. Moreover, dilation to A(2a) receptor activation with 2-p-(2-carboxyethyl)phenethylamino-5'-N-ethylcarboxamido-adenosine hydrochloride was reduced by the A(1) receptor agonist (2S)-N(6)-(2-endo-norbornyl)adenosine. The nonspecific calcium-activated potassium (K(Ca)) channel blocker tetrabutylammonium attenuated adenosine-induced dilation, as did the intermediate-conductance K(Ca) blocker clotrimazole. Neither the large-conductance K(Ca) blocker iberiotoxin nor small-conductance K(Ca) blocker apamin altered the dilation. In conclusion, adenosine endothelium independently dilates HCAs from patients with heart disease through a receptor-mediated mechanism that involves the activation of intermediate-conductance K(Ca) channels via an AC signaling pathway. The roles of A(1) and A(2) receptor subtypes are opposing, with the former being inhibitory to AC-mediated dilator actions of the latter. These observations identify unique fundamental physiological characteristics of the human coronary circulation and may help to target the use of novel adenosine analogs for vasodilation in perfusion imaging or suggest new strategies for myocardial preconditioning.

[1]  K. Chandy,et al.  Blockade of the Intermediate-Conductance Calcium-Activated Potassium Channel as a New Therapeutic Strategy for Restenosis , 2003, Circulation.

[2]  Takashi Saito,et al.  Pitavastatin Inhibits Upregulation of Intermediate Conductance Calcium-Activated Potassium Channels and Coronary Arteriolar Remodeling Induced by Long-Term Blockade of Nitric Oxide Synthesis , 2003, Pharmacology.

[3]  A. Nicolosi,et al.  Mechanism of thrombin-induced vasodilation in human coronary arterioles. , 2003, American journal of physiology. Heart and circulatory physiology.

[4]  A. Nicolosi,et al.  Diabetes Mellitus Impairs Vasodilation to Hypoxia in Human Coronary Arterioles: Reduced Activity of ATP-Sensitive Potassium Channels , 2003, Circulation research.

[5]  Takashi Saito,et al.  Role for Hydrogen Peroxide in Flow-Induced Dilation of Human Coronary Arterioles , 2003, Circulation research.

[6]  K. Varani,et al.  The FASEB Journal express article 10.1096/fj.02-0543fje. Published online December 3, 2002. Changes of peripheral A2A adenosine receptors in chronic heart failure and cardiac transplantation , 2022 .

[7]  W. Quist,et al.  Vascular smooth muscle cells derived from atherosclerotic human arteries exhibit greater adhesion, migration, and proliferation than venous cells. , 2002, The Journal of surgical research.

[8]  Takashi Saito,et al.  Role Of Augmented Expression Of Intermediate‐Conductance CA2+‐Activated K+ Channels In Postischaemic Heart , 2002, Clinical and experimental pharmacology & physiology.

[9]  I. Meredith,et al.  Effect of ATP-Sensitive Potassium Channel Inhibition on Resting Coronary Vascular Responses in Humans , 2002, Circulation research.

[10]  L. Rubin,et al.  Differential effects of stable prostacyclin analogs on smooth muscle proliferation and cyclic AMP generation in human pulmonary artery. , 2002, American journal of respiratory cell and molecular biology.

[11]  M. Pellegrino,et al.  Calmodulin antagonists do not inhibit IK(Ca) channels of human erythrocytes. , 2002, Biochimica et biophysica acta.

[12]  K. Yokote,et al.  Hyperglycemia-induced alteration of vascular smooth muscle phenotype. , 2002, Journal of diabetes and its complications.

[13]  D. Gutterman,et al.  High Glucose Impairs Voltage-Gated K+ Channel Current in Rat Small Coronary Arteries , 2001, Circulation research.

[14]  Takashi Saito,et al.  Flow-Induced Dilation of Human Coronary Arterioles: Important Role of Ca2+-Activated K+ Channels , 2001, Circulation.

[15]  P. Pagel,et al.  Diabetes and hyperglycemia impair activation of mitochondrial K(ATP) channels. , 2001, American journal of physiology. Heart and circulatory physiology.

[16]  L. Kuo,et al.  Functional and molecular characterization of receptor subtypes mediating coronary microvascular dilation to adenosine. , 2001, Journal of molecular and cellular cardiology.

[17]  B. Nilius,et al.  Ion channels and their functional role in vascular endothelium. , 2001, Physiological reviews.

[18]  I. Pang,et al.  AI Adenosine Receptors of Bovine Brain Couple to Guanine Nucleotide-binding Proteins Gil , Gi 2 , and Go * , 2001 .

[19]  H. Miura,et al.  Human coronary arteriolar dilation to adrenomedullin: role of nitric oxide and K(+) channels. , 2000, American journal of physiology. Heart and circulatory physiology.

[20]  P. Vanhoutte,et al.  Role of endothelial cell hyperpolarization in EDHF‐mediated responses in the guinea‐pig carotid artery , 2000, British journal of pharmacology.

[21]  L. Kuo,et al.  Adenosine A2A Receptors Mediate Coronary Microvascular Dilation to Adenosine: Role of Nitric Oxide and ATP-Sensitive Potassium Channels , 1999 .

[22]  R. Califf,et al.  Myocardial Infarction Adenosine as an Adjunct to Thrombolytic Therapy for Acute Myocardial Infarction , 1999 .

[23]  P. Reinhart,et al.  Molecular Cloning and Characterization of the Intermediate-Conductance Ca2+-Activated K+ Channel in Vascular Smooth Muscle , 1999 .

[24]  L. Kuo,et al.  cAMP-independent dilation of coronary arterioles to adenosine : role of nitric oxide, G proteins, and K(ATP) channels. , 1999, Circulation research.

[25]  H. Miura,et al.  Human coronary arteriolar dilation to bradykinin depends on membrane hyperpolarization: contribution of nitric oxide and Ca2+-activated K+ channels. , 1999, Circulation.

[26]  T. Cocks,et al.  Adenosine mediates relaxation of human small resistance‐like coronary arteries via A2B receptors , 1999, British journal of pharmacology.

[27]  P. Reinhart,et al.  Molecular cloning and characterization of the intermediate-conductance Ca(2+)-activated K(+) channel in vascular smooth muscle: relationship between K(Ca) channel diversity and smooth muscle cell function. , 1999, Circulation research.

[28]  D. Gutterman,et al.  Pharmacologic activation of the human coronary microcirculation in vitro: endothelium-dependent dilation and differential responses to acetylcholine. , 1998, Cardiovascular research.

[29]  T. Ishii,et al.  A human intermediate conductance calcium-activated potassium channel. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[30]  M. Hori,et al.  Amelioration of ischemia- and reperfusion-induced myocardial injury by 17beta-estradiol: role of nitric oxide and calcium-activated potassium channels. , 1997, Circulation.

[31]  Min-Cheol Song,et al.  Molecular constituents of maxi KCa channels in human coronary smooth muscle: predominant α+β subunit complexes , 1997 .

[32]  J. Shryock,et al.  Adenosine and adenosine receptors in the cardiovascular system: biochemistry, physiology, and pharmacology. , 1997, The American journal of cardiology.

[33]  M. Olah.  Identification of A2a Adenosine Receptor Domains Involved in Selective Coupling to GS , 1997, The Journal of Biological Chemistry.

[34]  L. Toro,et al.  Molecular constituents of maxi KCa channels in human coronary smooth muscle: predominant alpha + beta subunit complexes. , 1997, The Journal of physiology.

[35]  P. Zygmunt,et al.  Effects of cytochrome P450 inhibitors on potassium currents and mechanical activity in rat portal vein , 1996, British journal of pharmacology.

[36]  V. Gribkoff,et al.  Effects of channel modulators on cloned large-conductance calcium-activated potassium channels. , 1996, Molecular pharmacology.

[37]  G. Hansson,et al.  Expression of inducible nitric oxide synthase inhibits platelet adhesion and restores blood flow in the injured artery. , 1996, Circulation research.

[38]  J. Price,et al.  Inhbition of camp mediated relaxation in rat coronary vessels by block of Ca++ activated K+ channels , 1996 .

[39]  J. Price,et al.  Inhibition of cAMP mediated relaxation in rat coronary vessels by block of Ca++ activated K+ channels. , 1996, Life sciences.

[40]  A. Sollevi,et al.  Theophylline increases coronary vascular tone in humans: evidence for a role of endogenous adenosine in flow regulation. , 1995, Acta physiologica Scandinavica.

[41]  Syed Jamal Mustafa,et al.  Binding of A1 adenosine receptor ligand [3H]8-cyclopentyl-1,3-dipropylxanthine in coronary smooth muscle. , 1995, Circulation research.

[42]  T. Iwamoto,et al.  Identification of adenosine A2 receptor-cAMP system in human aortic endothelial cells. , 1994, Biochemical and biophysical research communications.

[43]  G. Gross,et al.  A comparison of adenosine-induced cardioprotection and ischemic preconditioning in dogs. Efficacy, time course, and role of KATP channels. , 1994, Circulation.

[44]  N. Standen,et al.  Adenosine‐activated potassium current in smooth muscle cells isolated from the pig coronary artery. , 1993, The Journal of physiology.

[45]  R. Bache,et al.  Endogenous adenosine and coronary vasoconstriction in hypoperfused myocardium during exercise. , 1993, Cardiovascular research.

[46]  P. Sternweis,et al.  A1 adenosine receptors of bovine brain couple to guanine nucleotide-binding proteins Gi1, Gi2, and Go. , 1991, The Journal of biological chemistry.

[47]  P. Ouyang,et al.  Blockade of the ATP-sensitive potassium channel modulates reactive hyperemia in the canine coronary circulation. , 1991, Circulation research.

[48]  A. Green,et al.  Decrease in A1 adenosine receptors in adipocytes from spontaneously hypertensive rats. , 1990, Metabolism: clinical and experimental.

[49]  G. Kaczorowski,et al.  Characterization of high affinity binding sites for charybdotoxin in synaptic plasma membranes from rat brain. Evidence for a direct association with an inactivating, voltage-dependent, potassium channel. , 1990, The Journal of biological chemistry.

[50]  J. Headrick,et al.  Contribution of adenosine to changes in coronary flow in metabolically stimulated rat heart. , 1988, Canadian journal of physiology and pharmacology.

[51]  A. D. Rodrigues,et al.  Interactions of imidazole antifungal agents with purified cytochrome P-450 proteins. , 1987, Biochemical pharmacology.

[52]  J. Angus,et al.  Relaxant effects of ATP and adenosine on canine large and small coronary arteries in vitro. , 1987, European journal of pharmacology.

[53]  H. W. Hamilton,et al.  PD 116,948, a highly selective A1 adenosine receptor antagonist. , 1987, Life sciences.

[54]  K. Magleby,et al.  Single apamin-blocked Ca-activated K+ channels of small conductance in cultured rat skeletal muscle , 1986, Nature.

[55]  J. Daly,et al.  Analogues of caffeine and theophylline: effect of structural alterations on affinity at adenosine receptors. , 1986, Journal of medicinal chemistry.

[56]  P. Silver,et al.  Adenosine-mediated relaxation and activation of cyclic AMP-dependent protein kinase in coronary arterial smooth muscle. , 1984, The Journal of pharmacology and experimental therapeutics.

[57]  J. Daly.  Physiology and pharmacology of adenosine derivatives , 1983 .

[58]  S. Downing,et al.  Coronary dilator actions of adenosine and CO2 in experimental diabetes. , 1982, The American journal of physiology.